TCL Archive Klausner Urges Emphasis On Research, Warns Against Shift To Health Programs. December 15, 2000
TCL Archive NCAB Rejects Automatic Loss Of Comprehensive Status For Center Without Core Grants September 29, 1978
TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive Conversation with TCL:Demetri: Morcellation Worsens Outcomes In Patients with Undiagnosed Cancers November 21, 2014
